Thursday, October 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Jefferies Analyst Initiates Coverage on ZoomInfo Technologies with a Buy Rating and 20 Price Target

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
Investing
0
SHARES
56
VIEWS
Share on FacebookShare on Twitter

On February 7, 2024, Jefferies analyst Surinder Thind took a leap in initiating coverage on ZoomInfo Technologies (NASDAQ: ZI) by bestowing it with a Buy rating. Furthermore, Thind confidently announced a price target of $20, unveiling an optimistic perspective on the company’s stock. This act of endorsement signifies a bright future for ZoomInfo Technologies.

ZI Stock Shows Decline in Price Momentum, Potential Buying Opportunity

On February 7, 2024, ZI stock experienced a slight decline in its price momentum. According to data from CNN Money, the stock was trading near the bottom of its 52-week range and below its 200-day simple moving average.

The price of ZI shares dropped by $0.02 since the market last closed, representing a decrease of 0.13%. The stock closed at $15.36. However, there seems to be some positive movement in pre-market trading, as the stock has risen by $0.43.

Trading near the bottom of its 52-week range suggests that the stock has been struggling to gain positive momentum and has been facing downward pressure. Investors may interpret this as a potential buying opportunity, as the stock may have reached a point of undervaluation.

The fact that the stock is trading below its 200-day simple moving average is another indication of its weak performance. The 200-day moving average is a commonly used technical indicator that helps investors assess the long-term trend of a stock.

It is worth noting that the pre-market trading activity shows a positive movement in the stock’s price. This indicates that there may be some optimism among investors, potentially driven by positive news or market sentiment.

In conclusion, ZI stock’s performance on February 7, 2024, showed a decline in price momentum, with the stock trading near the bottom of its 52-week range and below its 200-day simple moving average. The slight drop in price since the market last closed may have contributed to the stock’s underperformance. However, the rise in pre-market trading suggests some positive movement. Investors should exercise caution and conduct further analysis before making any investment decisions based on this information.

ZI Stock Performance: Mixed Bag with Revenue Growth but Concerns over Net Income and EPS

ZI Stock Performance: February 7, 2024

On February 7, 2024, ZI stock experienced a mixed performance, with some key financial indicators showing positive growth while others indicated a decline. Let’s delve into the details of the company’s performance based on the data provided by CNN Money.

Total revenue for ZI stood at $1.10 billion over the past year, representing a significant increase of 46.95% compared to the previous year. However, it is worth noting that the total revenue remained flat since the last quarter, indicating a potential slowdown in growth.

The net income for ZI in the past year was $63.20 million, reflecting a notable decrease of 45.89% compared to the previous year. Furthermore, the net income also decreased by 20.73% since the last quarter. This decline in net income could be a cause for concern for investors, as it indicates potential challenges faced by the company in maintaining profitability.

Earnings per share (EPS) is an important metric for investors to assess a company’s profitability on a per-share basis. ZI reported an EPS of $0.16 over the past year, which represents a significant decrease of 47.15% compared to the previous year. Additionally, the EPS also decreased by 19.83% since the last quarter. This decline in EPS further highlights the challenges faced by ZI in maintaining profitability and generating returns for its shareholders.

While ZI experienced strong revenue growth over the past year, the decline in net income and EPS is concerning. Investors may want to closely monitor the company’s financial performance in the coming quarters to assess whether these declines are temporary or indicative of a more significant issue.

In conclusion, ZI stock’s performance on February 7, 2024, was a mixed bag. While the company witnessed a substantial increase in total revenue since last year, the decline in net income and EPS raises concerns about its profitability. Investors should closely monitor ZI’s financial performance in the upcoming quarters to gain a better understanding of its trajectory and potential investment opportunities.

Tags: ZI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Investment (5)

Financial Analysts Express Optimism for Civitas Resources Stock Performance

Energy Company Markets and money

RBio Energy Corporations Transformative Journey Becoming a Publicly Traded Company

Finance_Commercial (2)

Lack of Information on Rosenblatts Analysis and Price Target for Sonos

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com